LBF20406LT06: Difference between revisions
No edit summary |
No edit summary |
||
(11 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR3115 | |LipidBank=XPR3115 | ||
|LipidMaps=LMFA03020013 | |LipidMaps=LMFA03020013 | ||
|SysName=5S,12R- | |SysName=(5S,12R) -Dihydroxy- (trans-6,trans-8,trans-10,cis-14) -eicosatetraenoic acid | ||
|Common Name=&&6-trans Leukotriene | |Common Name=&&6-trans Leukotriene B_4&&(5S,12R) -Dihydroxy- (6E,8E,10E,14Z) -eicosatetraenoic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=6-trans LTB4 is reported as a chemoattractant to neutrophils but the properties is relatively weal compared with LTB4.[[Reference:Fretland_DJ:Widomski_DL:Anglin_CP:Walsh_RE:Levin_S:Gaginella_TS:,J. Leukoc. Biol.,1991,49,283|{{RelationTable/GetFirstAuthor|Reference:Fretland_DJ:Widomski_DL:Anglin_CP:Walsh_RE:Levin_S:Gaginella_TS:,J. Leukoc. Biol.,1991,49,283}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Latest revision as of 07:51, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR3115 |
LipidMaps | LMFA03020013 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20406LT06 |
6-trans Leukotriene B4 | |
---|---|
Structural Information | |
(5S,12R) -Dihydroxy- (trans-6,trans-8,trans-10,cis-14) -eicosatetraenoic acid | |
| |
Formula | C20H32O4 |
Exact Mass | 336.23005951199997 |
Average Mass | 336.46567999999996 |
SMILES | C(CC=CC[C@H](C=CC=CC=C[C@H](CCCC(O)=O)O)O)CCC |
Physicochemical Information | |
6-trans LTB4 is reported as a chemoattractant to neutrophils but the properties is relatively weal compared with LTB4. Fretland_DJ et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|